Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury

Bibliography

• BUTCHER EC: The regulation of lymphocyte traffic. Curr. Top. Microbic)]. Immunol. (1986) 128:85–122.
   PubMed Web of Science ®Google Scholar
• SPRINGER TA: Adhesion receptors of the immune system. Nature (1990) 346:425–434.
   PubMed Web of Science ®Google Scholar
• ••One of the major contribution to the understandingadhesion receptors and their involvement in immunological processes.
   Google Scholar
• CARLOS TM, HARLAN JM: Membrane proteins involved in phagocyte adherence to endothelium. Immunol. Rev. (1990) 114:5.
   PubMed Web of Science ®Google Scholar
• CARLOS TM, HARLAN JM: Leukocyte-endothelial adhesion molecules. Blood (1994) 84:2068–2078.
   PubMed Web of Science ®Google Scholar
• SPRINGER TA, LASKY TA: Sticky sugars for selectins. Nature (1991) 349:196.
   PubMed Web of Science ®Google Scholar
• ••A very well writen paper on selectins: structure, functionand interactions.
   Google Scholar
• SPRINGER TA, LUCHER E, KLICKSTEIN LB et al:Adhesion structures: section report. In: Leukocyte Typing V: White Cell Differentiation Antigens. Schlossman SF, Boumsell L, Gilks W (Eds.) Oxford University Press, New York, USA (1995) :1443–1456.
   Google Scholar
• VAN DER MERWE PA, BARCLAY AN: Transient intercel-lular adhesion: the importance of weak protein-protein interactions. Trends Biochem. Sci. (1994) 19:354–358.
   PubMed Web of Science ®Google Scholar
• DUSTIN ML, STAUNTON DE, SPRINGER TA: Supergenefamilies meet in the immune system. Immunol. Today (1988) 9:213–215.
   PubMedGoogle Scholar
• •One of the first descriptions on the interactions of supergene families and their involvement in the regulation of immune reactions.
   Google Scholar
• BUTCHER EC: Cellular and molecular mechanisms that direct leukocyte traffic. (1990) 136:3–11.
   Google Scholar
• •An interesting article on the concept of leukocyte trafficking and its regulation by cellular and molecular mechanism.
   Google Scholar
• BUTCHER EC: Leukocyte-endothelial cell recognition: three (or more) steps of specificity and diversity. Cell (1991) 67:1033–1036.
   PubMed Web of Science ®Google Scholar
• HYNES RO: Integrins: Versatility, modulation and signalling in cell adhesion. Cell (1992) 69:11–25.
   PubMed Web of Science ®Google Scholar
• POBER JS, COTRAN RS: The role of endothelial cells in inflammation. Transplantation (1990) 50:537–544.
   PubMed Web of Science ®Google Scholar
• PARDI R, INVERARDI L, BENDER JR: Regulatorymechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers. Immunol. Today (1992) 13:224–230.
   PubMedGoogle Scholar
• POBER JS, COTRAN RS: The role of endothelial cells ininflammation. Transplantation (1990) 50:537–544.
   PubMed Web of Science ®Google Scholar
• STEINHOFF G, HAVERICH A: Cell-cell and cell-matrix adhesion molecules in human heart and lung transplants. Mol. Cell Biochem. (1995) 147:1–7.
   Google Scholar
• STEINHOFF G: Expression of adhesion molecules in human heart, liver and lung transplants. In: Adhesion molecules and cell signaling: biology and clinical applica-tion. Topic in Molecular Medicine, Vol: 1. Siess W, Lorenz R, Weber PC (Eds.) Raven Press, New York, USA (1995).
   Google Scholar
• LEWISOHN DM, BARGATZE RF, BUTCHER EC: Leukocyte endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes and other leukocytes. J. Immunol. (1987) 138:4313–4321.
   PubMed Web of Science ®Google Scholar
• VON ANDRIAN VH, CHAMBERS JD, MCENVOY LM et al.:Two-step model of leukocyte-endothelial cell interac-tion in inflammation: distinct roles of LECAM-1 and the leukocyte 82 integrins in vivo. Proc. Natl. Acad. Sci. USA (1991) 88:7538–7542.
   PubMed Web of Science ®Google Scholar
• CLAVIEN PA, HARVEY PRC, STRASBERG SM: Preservation and reperfusion injuries in liver allografts. Transplan-tation (1992) 53:957–978.
   PubMed Web of Science ®Google Scholar
• STEINHOFF G, BEHREND M, SCHRADER B et al: Expres-sion patterns of leucocyte adhesion ligand molecules on human liver endothelia: lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3. Am. J. Path. (1993) 142:481–488.
   PubMed Web of Science ®Google Scholar
• STEINHOFF G, BEHREND M, SCHRADER et al.: Intercel-lular immune adhesion molecules in human liver transplants-Overview on expression patterns of leukocyte receptor and ligand molecules. Hepatology (1993) 18:440–453.
   PubMed Web of Science ®Google Scholar
• KOOYK VY, ZWAN AV, WAAL LP, FIGDOR CG: Efficiency of antibodies directed against adhesion molecules to prolong skin graft survival in mice. Transplant Proc. (1994) 26:401.
   PubMed Web of Science ®Google Scholar
• ISOBE M, SUZUKI JI, YAMAZAKI S, SEKIGUCHI M:Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice. Transplantation (1996) 62:411–413.
   PubMed Web of Science ®Google Scholar
• MULLER DL, JENKINS MK, SCHWARTZ FL: Clonal expansion versus functional clonal inactivation: A costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Ann. Rev. Immunol. (1989) 7:445.
   PubMed Web of Science ®Google Scholar
• TAMATANI T, KOTANI M, MIYASAKA M: Characteriza-tion of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit specific monoclonal antibodies. Eur. J. Immunol. (1991) 21:627.
   PubMed Web of Science ®Google Scholar
• IWATA T, KAMEI Y, ESAKI S et al.: Immunosuppressionby anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection. ImmunoBiol. (1996) 195:160–171.
   PubMed Web of Science ®Google Scholar
• COSIMI AB, CONTI D, DELMONICO FL et al.: In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol (1990) 144:4604–4612.
   PubMed Web of Science ®Google Scholar
• ••This is a very detailed description of the experimentalprotocol with a monoclonal antibody against ICAM-1 in the treatment and prevention of renal allograft rejection. It give a lot of detailed information and is extensively cited in this review.
   Google Scholar
• COSIMI AB, GEOFFRIAN C, ANDERSON T, CONTI D, ROTHLEIN R, COLVIN RB: Immunosuppression of Cynomolgus recipients with renal allografts by R6.5, a monoclonal antibody to ICAM-1. In: Leukocyte Adhesion Molecules. Springer TA, Anderson DC, Rothlein R, Rosenthal AS (Eds.) Springer-Verlag, Berlin FRG (1989):274–281.
   Google Scholar
• HALLER H, DRAGUN D, MIETHKE A, PARK JK: Oligonu-cleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int. (1996) 50:473–480.
   PubMed Web of Science ®Google Scholar
• •One of the best report on the use of antisense oligonucelo-tides for ICAM-1 in experimental transplantation.
   Google Scholar
• DRAGUN D, TULLIUS SG, PARK JK et al.: ICMA-1 antisense oligodesoxynucleotides prevent reperfu-sion injury and enhance immediate graft function in renal transplantation. Kidney Int. (1998) 54:590–602.
   PubMed Web of Science ®Google Scholar
• DRAGUN D, LUKITSCH I, TULLIUS SG et al.: Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat. Kidney Int. (1998) 54:2113–2122.
   PubMed Web of Science ®Google Scholar
• KELLY KJ, WILLIAMS WW, COLVIN RB et al.: Intercellular Adhesion Molecule-l-deficient mice are protected against ischemic renal injury. J. Clin. Invest. (1996) 97:1056–1063.
   PubMed Web of Science ®Google Scholar
• XU H, GONZALO JA, ST. PIERRE Y et al.: Leukocytosis andresistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. (1994) 180:95–109.
   Google Scholar
• ISOBE M, SUZUKI J, YAGITA H et al.: Immunosuppres-sion to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. J. Immunol. (1994) 153:5810–5818.
   PubMed Web of Science ®Google Scholar
• OROSZ CG, OHYE RG, PELLETIER RP et al.: Treatmentwith anti-vascular cell adhesion molecule-1 monoclonal antibody induces long-term murine cardiac allografts acceptance. Transplantation (1993) 56:453–460.
   PubMed Web of Science ®Google Scholar
• GROOBY WL, KRISHNAN R, JOHNSTON JK, RAO MM,RUSS GR: Combined anti-vascular cell adhesion molecule-1 and anti-leukocyte function-associated molecule-1 monoclonal antibody therapy does not prolong allograft survival in an ovine model of renal transplantation. Transplantation (1998) 66:920–924.
   PubMed Web of Science ®Google Scholar
• GROOBY W, KRISHNAN R, RUSS G Anti-ovine VCAM-1 monoclonal antibodies inhibit adhesion and proliferation between sheep endothelial and mononu-clear cells in vitro. Immunol Cell Biol. (1997) 75:546.
   PubMed Web of Science ®Google Scholar
• GROOBY WL, CARTER JK, RAO MM et al.: Use of an anti-LFA-1 antibody in renal allograft rejection in sheep. Transplant Proc. (1992) 24:2304.
   PubMed Web of Science ®Google Scholar
• VONDERHEIDE RH, SPRINGER TA: Lymphocyte adhesion through very late antigen-4: evidence for a novel binding site in the alternatively spliced domain of vascular cell adhesion molecule-1 and additional 4 integrin counter-receptor on stimulated endothelium. J. Exp. Med. (1992) 175:1433.
   PubMed Web of Science ®Google Scholar
• CHULUYAN HE, OSBORN L, LOBB R, ISSEKUTZ AC: Domains 1 and 4 of vascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration. J. Immunol. (1995) 155:3135.
   PubMed Web of Science ®Google Scholar
• POLTE T, NEWMAN W, GOPAL TV: Full length vascular cell adhesion molecule 1 (VCAM-1). Nucleic Adds Res. (1990) 18:5901.
   PubMed Web of Science ®Google Scholar
• ISOBE M, YAGITA H, OKUMURA K, IHARA A: Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science (1992) 255:1125–1127.
   PubMed Web of Science ®Google Scholar
• ••Tolerance induction by monoclonal antibodies to ICAM-1and LFA-1 - at least in an experimental situation.
   Google Scholar
• TAKEI F: Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lympho-cyte activation antigen (MALA-2). J. Immunol (1985) 134:1403–1407
   PubMed Web of Science ®Google Scholar
• PRIETO J, TAKEI F, GENDELMAN R, CHRISTENSON B, BIBERFELD P, PATARROYO M: MALA-2, mouse homologue of human adhesion molecule ICAM-1 (CD54). Eur. j Immunol. (1989) 19: 1551–1557
   PubMed Web of Science ®Google Scholar
• NISHIMURA T, YAGI H, SATO N, OHTA S, HASHIMOTO Y:The role of lymphokine-activated cell-associated antigen. III. Inhibition of T-cell activation by monoclonal killer-blocking antibody. Cell Immunol. (1987) 107:32–39
   Google Scholar
• NISHIMURA T, YAGI H, YAGITA H, UCHIYAMA Y, HASHIMOTO Y: Lymphokine-activated cell-associated antigen involved in broad-reactive killer cell-mediated cytotoxicity. Cell Immunol. (1985) 94:122–132
   PubMed Web of Science ®Google Scholar
• NAKAKURA E, JARDEAU P, ZHENG B, MORRIS R: An anti-adhesion molecule (LFA-1, CD110 monoclonal antibody suppresses ongoing rejection and prolongs heart allograft survival indefinitely without lympho-cyte depletion. J. Heart Lung Transplant (1992) 11:223.
   Google Scholar
• WARREN R, LOFGREEN J, STEINMULLER D: Differentialsurvival of heart and skin allografts in inbred rats. Transplant Proc. (1973) 5:717.
   PubMed Web of Science ®Google Scholar
• TRAGER D, BANKS B, ROSENBAUM G et al: Cardiac allograft prolongation in mice treated with combined posttransplantation total-lymphoid irradiation and anti-L3T4 antibody therapy. Transplantation (1989) 47:587.
   PubMed Web of Science ®Google Scholar
• NAKAMURA EK, MCCABE SM, ZHENG B et al. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. Transplantation (1993) 55:412–417.
   PubMed Web of Science ®Google Scholar
• CHAVIN K, BROMBERG J: Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival and decrease the associated cytokine syndrome. Surg. Forum (1992) 43:391.
   Google Scholar
• STEPKOWSKI S, YIZHENG T, CONDON TP, BENNETT CF:Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol (1994) 153:5336–5346.
   PubMed Web of Science ®Google Scholar
• STEPKOWSKI SM, TU Y, CONDON TP, BENNETT CF: Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies. Transplant Proc. (1995) 27:113.
   PubMed Web of Science ®Google Scholar
• ISOBE M, SUZUKI JI, YAGITA H et al.: Immunosuppres-sion to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-Very Late Antigen-4 monoclonal antibodies. J. Immunol. (1994) 153:5810–5818.
   PubMed Web of Science ®Google Scholar
• MIYAKE K, MEDINA K, ISHIHARA K, KIMOTO M, AUERBACH R, KINCADE PW: A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture. J. Cell Biol. (1991) 114:557.
   PubMed Web of Science ®Google Scholar
• HESSION C, P MOY, TIZARD et al.: Cloning of murineand rat vascular cell adhesion molecule-1. Biochem. Biophys. Res. Commun. (1992) 183:163.
   PubMed Web of Science ®Google Scholar
• MIYAKE K, WEISSMAN IL, GREENBURGER JS, KINCADEPW: Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. (1991) 173:599.
   PubMed Web of Science ®Google Scholar
• ISOBE M, SUZUKI J, YAMAZAKI S, SEKIGUCHI M: Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies. Transplant Proc. (1996) 28:1045–1046.
   PubMed Web of Science ®Google Scholar
• ISOBE M, SUZUKI JI, YAMAZAKI S et al.: Regulation of differential development of Thl and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation (1997) 96:2247–2253.
   PubMed Web of Science ®Google Scholar
• BASHUDA H, TAKAZAWA K, TAMATANI T, MIYASAKA M,YAGITA H, OKUMURA K: Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion and FK-506. Transplantation (1996) 62:117–122.
   PubMed Web of Science ®Google Scholar
• BRANDT M, STEINMANN J, STEINHOFF G, HAVERICH A:Treatment with monoclonal antibodies to ICAM-1 and LFA-1 in rat heart allograft rejection. Transpl. Int. (1997) 10:141–144.
   PubMed Web of Science ®Google Scholar
• KOSKINEN PK, LEMSTROM KB: Adhesion molecule P-selectin and vascular cel adhesion molecule-1 in endanced heart allograft arteriosclerosis in the rat. Circulation (1997) 95:191–196.
   PubMed Web of Science ®Google Scholar
• TANAKA H, SUKHOVA GK, SWANSON SJ, CYBULSKY MI, SCHOEN FJ, LIBBY P: Endothelial and smooth muscle cells express leukocyte adhesion molecules heteroge-neously during acute rejection of rabbit cardiac allografts. Am. J. Path. (1994) 144:938–951.
   PubMed Web of Science ®Google Scholar
• GROCHOWICZ PM, HIBBERD AD, SMART YC et al: Castanospermine, an oligosaccharide processing inhibitor, reduces membrane expression of adhesion molecules and prolongs heart allograft survival in rats. Transplant Immunol. (1996) 4:275–285.
   PubMedGoogle Scholar
• HARIHARA Y, SAKAMOTO H, SANJO K, OTSUBO O, WATANABE G, IDEZUKI Y: Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1. Transplant Proc. (1994) 26:2258.
   PubMed Web of Science ®Google Scholar
• DEGAWA H, WATANABE K, UCHIDA H et al.: Blocking ofICAM-1 and LFA-1 in Rat Liver Transplantation. Transplant Proc. (1996) 28:1362–1363.
   PubMed Web of Science ®Google Scholar
• NAKANO H, KUZUME M, NAMATAME K, YAMAGUCHI M,KUMADA K: Efficacy of intraportal injection of anti-ICAM-1 monoclonal antibody against liver cell injury following warm ischemia in the rat. Am. J. Surg. (1995) 170:64–66.
   PubMed Web of Science ®Google Scholar
• HARIHARI Y, SUGAWARA Y, INOUE K et al.: Dose-dependent immunosuppressive effects of antibodies to ICAM-1 and LFA-1 on hepatic allografts. Transplant Proc. (1996) 28:1794–1795.
   PubMed Web of Science ®Google Scholar
• TAMATANI T, MIYASAKA M: Identification ofmonoclonal antibodies reactive with the rat homolog of ICAM-1, and evidence for a differential involvement of ICAM-1 in the adherence of resting versus activated lymphocytes to high endothelial cells. Int. Immunol. (1990) 2:165–171
   PubMed Web of Science ®Google Scholar
• TAMATANI T, KOTANI M, MIYASAKA M: Characteriza-tion of the rat leukocyte integrin, CD11/CD18, by the use of LFA-1 subunit-specific monoclonal antibodies. Eur. j Immunol. (1991) 21:627–633
   PubMed Web of Science ®Google Scholar
• OTTO C, GASSER M, GASSEL HJ et al.: Selective Immuno-suppression with FK-506, Anti-IL-2R and Anti-ICAM-1 monoclonal antibodies: Contrasting effects after liver and small bowel transplantation in rats. Transplant Proc. (1998) 30:2161–2162.
   PubMed Web of Science ®Google Scholar
• GASSER M, TIMMERMANN. W, VOWINKEL T et al.: Effectof selective immunosuppression with FK 506, Anti-IL-2R and Anti-ICAM-1 MAb in Rat Smoll Bowel Transplantation. Transplant Proc. (1998) 30:2605–2606.
   Google Scholar
• YAMATAKA T, KOBAYASHI H, YAGITA H, OKUMURA K,TAMATANI T, MIYASAKA M: The effect of anti-ICAM-1 monoclonal antibody treatment on the transplanta-tion of the small bowel in rats. J. Pediatr. Surg. (1993) 28:1451–1457
   PubMed Web of Science ®Google Scholar
• KAWABE A, KIMURA T, SUZUKI H, SUZUKI K, HARADA Y: Anti-Adhesion (Anti-ICAM-1 and Anti-LFA-1) Therapy in a Rat Pancreas Transplantation Model. Transplant Proc. (1996) 28:1808.
   PubMed Web of Science ®Google Scholar
• GOTOH M, FUKUZAKI T, MONDEN M et al.: A potential immunosuppressive effect of anti-lympocyte function-associated antigen-1 monoclonal antibody on islet transplantation. Transplantation (1994) 57:123–126.
   PubMed Web of Science ®Google Scholar
• NISHIMURA T, YAGI H, SATO N, OHTA S, HASHIMOTO Y:The role of lymphokine-activated cell-associated antigen. III. Inhibition of T-cell activation by monoclonal killer-blocking antibody. Cell Immunol. (1987) 107:32.
   Google Scholar
• YAGITA H, NAKAMURA H, KARASUYAMA H, OKUMURAK: Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. Proc. Nati Acad. Sci. USA (1989) 86:645.
   PubMed Web of Science ®Google Scholar
• YANG H, ISSEKUTZ TB, WRIGHT JR: Treatment with anti-VLA-4 and LFA-1 monoclonal antibodies prolongs intraportal rat islet allograft survival. Transplant Proc. (1994) 26:3325–3326.
   PubMed Web of Science ®Google Scholar
• YANG H, ISSEKUTZ TB, WRIGHT JR: Prolongation of ratislet allograft survival by treatment with monoclonal antibodies against VLA-4 and LFA-1. Transplantation (1995) 60:71–76.
   PubMed Web of Science ®Google Scholar
• ISSEKUTZ TB, WYKRETOWICZ A: Effect of a new monoclonal antibody, TA-2, that inhibits lymphocyte adherence to cytokine stimulated endothelium in the rat. J. Immunol. (1991) 147:109.
   PubMed Web of Science ®Google Scholar
• ISSEKUTZ TB: Inhibition of in vivo lymphocytemigration to inflammation and homing to lymphoid tissues by TA-2 monoclonal antibody: a likely role of VLA-4 in vivo. J. Immunol. (1991) 147:4178.
   PubMed Web of Science ®Google Scholar
• ISSEKUTZ TB: Inhibition of lymphocyte endothelialadhesion and in vivo lymphocyte migration to cutaneous inflammation by TA-3, a new monoclonal antibody to rat LFA-1. J. Immunol. (1992) 149:3394.
   PubMed Web of Science ®Google Scholar
• YU W, WAN X, WRIGHT JR, CODDINGTON D, BITTER-SUERMANN H: Heterotopic liver transplantation in rats: effect of intrahepatic islet isografts and split portal blood flow on liver integrety after auxiliary liver isotransplantation. Surgery (1994) 115:108.
   PubMed Web of Science ®Google Scholar
• NAKAO Y, MACKINNON SE, MOHANAKUMAR T et al.:Monoclonal antibodies against ICAM-1 and LFA-1 (CD11A) induce specific tolerance to peripheral nerve allograft in rats. Transplant Proc. (1995) 27:373–377.
   PubMed Web of Science ®Google Scholar
• GENDEN EM, MACKINNON SE, YU S, FLYE MW: Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies. Surgery (1998) 124:448–456.
   PubMed Web of Science ®Google Scholar
• HARIHARA Y, SUGAWARA Y, INOUE K et al.: Dose-dependent immunosuppressive effects of antibodies to ICAM-1 and LFA-1 on hepatic allografts. Transplant Proc. (1996) 28:1794–1795.
   PubMed Web of Science ®Google Scholar
• FISCHER A, BLANCHE S, VEBER F et al.: Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation. Lancet (1986) 2:1058–1061.
   PubMed Web of Science ®Google Scholar
• ••The first clinical report on the use of a anti-LFA-1monoclonal antibody for the prevention of graft failure in bone-marrow transplantation.
   Google Scholar
• HAUG CE, COLVIN RB, DELMONICO FL et al.: A Phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation (1993) 55:766–773.
   PubMed Web of Science ®Google Scholar
• •The first report on the clinical use of anti-ICAM-1 in human renal allograft recipients.
   Google Scholar
• ARGENBRIGHT LW, LETTS LG, ROTHLEIN R: Monoclonalantibodies to the leukocyte membrane CD18 glycopro-tein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits. J. Leukoc. Biol. (1991) 49:253–257.
   PubMed Web of Science ®Google Scholar
• COSIMI AB, CONTI D, DELMONICO FL et al: In vivoeffects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. (1990) 144:4604.
   PubMed Web of Science ®Google Scholar
• CHATENOUD L, FERRAN D, LEGENDRE C et al: In vivocell activation following OKT3 administration. Transplantation (1990) 49:697.
   PubMed Web of Science ®Google Scholar
• SALMELA K, WRAMNER L, EKBERG H et al: A randomizedmulticenter trial of the anti-ICAM-1 monoclonal antibody (enlimomAb) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation. Transplantation (1999) 67:729–736.
   PubMed Web of Science ®Google Scholar
• LE DEIST F, BLANCHES, KEABLE H eta].: Successful HLAnon identical bone marrow transplantation in three patients with LAD. Blood (1989) 74:512–519.
   Google Scholar
• FISCHER A, BLANCHE S, VEBER F et al: Correction ofimmune disorders by HLA matched and mismatched bone marrow transplantation. In: Recent advances in bone marrow transplantation. Gale RP, (Ed.) Alan R Liss, New York, USA (1983).
   Google Scholar
• OLIVE D, CHARMOT D, DUBREUIL P et al.: Human lymphocyte functional antigens. In: Human T-cell clones: A new approach to immune regulation. Feldmann M, (Ed.) Humana Press, Clifton, New Jersey, USA (1986):173–187.
   Google Scholar
• KRENSKY AM, ROBBINS E, SPRINGER TA, BURAKOFF SJ: LFA-1, LFA-2 and LFA-3 antigens are involved in CTL-target conjugation. J. Immunol. (1 9 8 4) 132:2180-2185.
   Google Scholar
• FISCHER A, FRIEDRICH W, FASTH A et al.: Reduction ofgraft failure by a monoclonal antibody (anti-LFA-1/CD110 after HLA non identical bone marrow transplantation in children with immunode-ficiencies, osteopetrosis and Fanconi's anemia. Blood (1991) 77:249–256.
   PubMed Web of Science ®Google Scholar
• LE MAUFF B, HOURMANT M, ROUGIER JP et al.: Effect ofanti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplan-tation (1991) 52:291–296.
   PubMed Web of Science ®Google Scholar
• HOURMANT M, LE MAUFF B, LE MEUR Y et al.: Administration of an anti-CD1 la monoclonal antibody in recipients of kidney transplantation. A pilot study. Transplantation (1994) 58:377–380.
   Google Scholar
• LE MAUFF B, LE MEUR. Y, HOURMANT M et al: A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipients. Kidney Int. (1996) 53:S44–S50.
   Google Scholar
• OLIVE D, CHARMOT D, DUBREUIL P: Human lympho-cyte functional antigens. In: Human T-cell clones: An new approach to immune regulation. Felmann. M, (Ed.) Humana Press, Clifton, NJ, USA (1986):173.
   Google Scholar
• LE MAUFF B, HOURMANT M, ROUGIER JP et al.: Effect of anti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in of human kidney transplanta-tion. Transplantation (1991) 52: 291–296
   PubMed Web of Science ®Google Scholar
• HOURMANT M, BEDROSSIAN J, DURAND D et al.: Multicenter comparative study of an Anti-LFA-1 adhesion molecule monoclonal antibody and antithy-mocyte globulin in prophylaxis of acute rejection in kidney transplantation. Transplant Proc. (1995) 27:864.
   PubMed Web of Science ®Google Scholar
• GALEA P, LEBRANCHU A, THIBAULT G, BARDOS P: Interleukine 4 and tumor necrosis factor a induce different adhesion pathways in endothelial cells for the binding of peripheral blood lymphocytes. Scand.J. Immunol. (1992) 36:575.
   PubMed Web of Science ®Google Scholar
• BROCKMEYER C, ULBRECHT M, SCHENDEL DJ et al.: Distribution of cell adhesion molecules (ICAM1, VCAM1, ELAM° in renal tissue during allograft rejection. Transplantation (1993) 55:610.
   PubMed Web of Science ®Google Scholar
• WELLICOME SM, THRONHILL MH, PITZALIS C et al.: A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by TNF, IL1 or LPS. J. Immunol. (1990) 144:2558.
   PubMed Web of Science ®Google Scholar
• MCCORD J: Oxygen-derived free radicals in post-ischemic tissue injury. N. Eng] J. Med. (1985) 3 12:159.
   Google Scholar
• LINAS SL, SHANLEY PF, WHITTENBURG D, BERGER E, REPINE JE: Neutrophils accentuate ischemia-reperfusion injury in the isolated perfused kidney. Am. J. Physic)]. (1988) 255:F728.
   Google Scholar
• YOSHIDA N, GRANGER D, ANDERSON D, ROTHLEIN R, LANE C, KVIETYS P: Anoxia/reoxygenation induce neutrophil adherence to cultured endothelial cells. Am. J. Physic)]. (1992) 262:H1891.
   PubMed Web of Science ®Google Scholar
• DUSTIN ML, ROTHLEIN R, BHAN AK, DINARELLO CA, SPRINGER TA: Induction by TNF and interferon gamma. Tissue distribution, biochemistry and function of ICAM1. J. Immunol (1986) i37:245.
   Google Scholar
• OJO AO, WOLFE RA, HELD PJ et al.: Risk factors and influence of delayed graft function on renal allograft survival. 15th Annual Meeting of the American Society of Transplant Physicians. Dallas, Texas, USA May 26–30, (1996) Abstract.
   Google Scholar
• KAMEOKA H, ISHIBASHI M, TAMATANI T et al.:Compara-tive immunosuppressive effect of anti-CD18 and anti-CD1 la monoclonal antibodies on rat heart allotransplantation. Transplant Proc. (1993) 25:833–836.
   PubMed Web of Science ®Google Scholar
• KAMEOKA H, ISHIBASHI M, TAMATANI T et al.: The immunosuppressive action of anti-CD18 monoclonal antibody in rat heterotopic heart allotransplantation. Transplantation (1993) 55:665–667.
   PubMed Web of Science ®Google Scholar
• BRANDT M, BOEKE K, STEINHOFF G: Inhibition of leukocyte rolling by fucoidin prevents lung allograft rejection and reperfusion injury. J. Heart Lung Transplant (1997b) 16:81.
   Google Scholar
• PAUL LC, DAVIDOFF A, PAUL DW et al.: Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitits in rat cardiac allografts. Transplant Proc. (1993) 25:813–814.
   PubMed Web of Science ®Google Scholar
• PAUL LC, DAVIDOFF A, BENEDIKTSSON H et al.: The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplanta-tion (1993) 55:1196–1199.
   PubMed Web of Science ®Google Scholar
• PAUL LC, DAVIDOFF A, PAUL DW et al.: Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts. Transplant Proc. (1993) 25:813–814.
   PubMed Web of Science ®Google Scholar
• HARRISON PC, MADWED JB: Anti-ICAM-1 does not prolong, but act synergistically with cyclosporin A to extend cardiac allograft survival in heterotopically transplanted rats. J. HeartLung Transplant (1996) 15:65.
   Google Scholar
• KOMORI A, NAGATA M, OCHIAI T et al.: Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat. Transplant Proc. (1993) 25:831.
   PubMed Web of Science ®Google Scholar
• FLAVIN T, IVENS K, ROTHLEIN et al.. Monoclonal antibodies against Intercellular Adhesion Molecule 1 prolong cardiac allograft survival in cynomolgus monkeys. Transplant Proc. (1991) 23:533–534.
   PubMed Web of Science ®Google Scholar
• SADAHIRO M, MCDONALD TO et al.: CD18 receptors may be a better target than ICAM-1 ligands for reducing histologic evidence of cellular and vascular rejection in the rabbit. Transplant Int. (1995) 8:452–458.
   PubMed Web of Science ®Google Scholar
• GERRITSEN ME, CARLEY WW, RANGES GE et al.: Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J. Path. (1995) 147:278–292.
   PubMed Web of Science ®Google Scholar
• SCHOWENGERDT KO, ZHU JY, STEPKOWSKI SM et al: Cardiac allograft survival in mice deficient in intercel-lular adhesion molecule-1. Circulation (1995) 92:82–87.
   PubMed Web of Science ®Google Scholar
• STEPKOWSKI SM, WANG ME, AMANTE A et al.: Antisense ICAM-1 oligonucleotides block allograft rejection in rats. Transplant Proc. (1997) 29:1285.
   PubMed Web of Science ®Google Scholar
• HARIHARA Y, SUGAWARA Y, INOUE K et al.: Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts. Transplant Proc. (1996) 28:1368–1369.
   PubMed Web of Science ®Google Scholar